genome editing

Genome Editing

New England Biolabs provides reagents to support a broad variety of CRISPR/Cas9 genome editing approaches. From introduction of Cas9 and single guide RNA (sgRNA) on plasmids, to direct introduction of Cas9 ribonucleoprotein (RNP) and detection of edits using next generation sequencing or enzymatic mutation detection. NEB provides reagents that simplify and shorten genome editing workflows.

Protocols for Genome Editing

Legal Information

This product is covered by one or more patents, trademarks and/or copyrights owned or controlled by New England Biolabs, Inc (NEB).

While NEB develops and validates its products for various applications, the use of this product may require the buyer to obtain additional third party intellectual property rights for certain applications.

For more information about commercial rights, please contact NEB's Global Business Development team at gbd@neb.com.

This product is intended for research purposes only. This product is not intended to be used for therapeutic or diagnostic purposes in humans or animals.

  1. $name

    Cas9 in vivo: Bacterial Adaptive Immunity

    CRISPR systems evolved as a means of bacterial adaptive immunity. Understanding their behavior in vivo is essential to harnessing their power in vitro.

  2. NEB TV Episode 7

    Science in 60 CRISPR/Cas9

    Get a high level overview of CRISPR/Cas9 and how it is used in genome editing in our Science in 60 segment.